NGL FINECHEM
Back to Balance Sheet
|
NGL FINECHEM Last 5 Year Secured Loans History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Secured Loans | ₹56 Cr | ₹25 Cr | ₹0.75 Cr | ₹2.07 Cr | ₹3.44 Cr |
What is the latest Secured Loans ratio of NGL FINECHEM ?
| Year | Secured Loans |
|---|---|
| Mar2026 | ₹56 Cr |
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹0.75 Cr |
| Mar2023 | ₹2.07 Cr |
| Mar2022 | ₹3.44 Cr |
How is Secured Loans of NGL FINECHEM Trending?
| Years | Secured Loans | % Change | |
|---|---|---|---|
| Mar2026 | ₹56 Cr | 122.62 | |
| Mar2025 | ₹25 Cr | 3,300.81 | |
| Mar2024 | ₹0.75 Cr | -64.06 | |
| Mar2023 | ₹2.07 Cr | -39.67 | |
| Mar2022 | ₹3.44 Cr | - | |
Compare Secured Loans of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,639.4 Cr | -5.9% | -7.1% | 77.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | -5.9% |
-7.1% |
77.6% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses